Who Owns SABS?

SAB Biotherapeutics, Inc. — Institutional Ownership & 13F Holdings

$3.47

-0.06 (-1.70%)

Market Cap

$33.2M

Shares Outstanding

9,558,166

Institutional Holders

26

Total Inst. Value

$2.9M

% of Float Held

27.9%

QoQ Holder Change

+4

Institutional data as of Q1 2025

New Positions

6

Closed Positions

4

Increased

6

Decreased

6

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1BVF INC/IL$1.2M917,826
2Sessa Capital IM, L.P.$624K458,457
3VANGUARD GROUP INC$374K277,510
4HB Wealth Management, LLC$357K263,200
5GEODE CAPITAL MANAGEMENT, LLC$114K84,685
6BlackRock, Inc.$30K22,301
7SILVER OAK SECURITIES, INCORPORATEDNew$30K20,188
8Kovitz Investment Group Partners, LLC$26K19,201
9First PREMIER BankNew$26K18,986
10XTX Topco LtdNew$22K16,555

Biggest Buyers & Sellers This Quarter

Top Sellers

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold SABS?

As of Q1 2025, 26 institutional investors report holding SABS (SAB Biotherapeutics, Inc.) in their 13F filings.

What percentage of SAB Biotherapeutics, Inc. is owned by institutions?

Institutional investors hold approximately 27.9% of SAB Biotherapeutics, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most SABS?

The largest institutional holder of SABS is BVF INC/IL with $1.2M in shares.

Are institutions buying or selling SABS?

This quarter, 6 institutions opened new positions in SABS and 4 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.